C&EN’s Year in Pharma 2022: The roller-coaster ride continued for Alzheimer’s drug candidatesnews2022-12-02T13:55:38+00:00December 2nd, 2022|Chemical & Engineering News|
C&EN’s Year in Pharma 2022: Genetic therapies kept moving from lab to clinicnews2022-12-02T13:55:31+00:00December 2nd, 2022|Chemical & Engineering News|
Periodic Graphics: Fuels for space travelnews2022-12-02T13:46:18+00:00December 2nd, 2022|Chemical & Engineering News|
China’s challenge in the drug services fieldnews2022-12-02T13:46:10+00:00December 2nd, 2022|Chemical & Engineering News|
Tattoo industry faces an ink makeovernews2022-12-02T13:45:58+00:00December 2nd, 2022|Chemical & Engineering News|
Shankar Balasubramanian is thinking beyond DNA’s four-letter codenews2022-12-02T13:45:45+00:00December 2nd, 2022|Chemical & Engineering News|
EU partially reverses TiO₂ bansnews2022-12-02T04:21:36+00:00December 2nd, 2022|Chemical & Engineering News|
Grumpy hamsters and clammed-up clamsnews2022-12-02T04:21:14+00:00December 2nd, 2022|Chemical & Engineering News|
Make it easier to connect with colleaguesnews2022-12-02T04:20:06+00:00December 2nd, 2022|Chemical & Engineering News|
Negotiators tackle first round of talks to control plastic pollutionnews2022-12-02T00:30:22+00:00December 2nd, 2022|Chemical & Engineering News|
